Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Ivermectin 12mg or Ivermectin 36mg single dose orally once only: The study will have two intervention arms. In the intervention Arm 1: 12mg oral Ivermectin will be given to the close family contacts fulfilling the inclusion- exclusion criteria for this study; of the newly diagnosed Covid-19 patient within 24 hours of diagnosis. The drug will be given orally and once only (under supervision). In the intervention Arm 2: 36 mg oral Ivermectin will be given to the close family contacts fulfilling the inclusion- exclusion criteria for this study; of the newly diagnosed Covid-19 patient within 24 hours of diagnosis. The drug will be given orally and once only (under supervision).Control Intervention1: Two Multivitamin tablets: In the control group - each participant will be given 2 (two) multivitamin tablets (available in the supply at the study institute). These tablets will be given orally; under-supervision and only once.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Ivermectin 12mg or Ivermectin 36mg single dose orally once only: The study will have two intervention arms. In the intervention Arm 1: 12mg oral Ivermectin will be given to the close family contacts fulfilling the inclusion- exclusion criteria for this study; of the newly diagnosed Covid-19 patient within 24 hours of diagnosis. The drug will be given orally and once only (under supervision). In the intervention Arm 2: 36 mg oral Ivermectin will be given to the close family contacts fulfilling the inclusion- exclusion criteria for this study; of the newly diagnosed Covid-19 patient within 24 hours of diagnosis. The drug will be given orally and once only (under supervision).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Two Multivitamin tablets: In the control group - each participant will be given 2 (two) multivitamin tablets (available in the supply at the study institute). These tablets will be given orally; under-supervision and only once.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

Nov. 13, 2021, 5:33 p.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

Oct. 26, 2020, 8:29 a.m. oms

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Ivermectin 12mg or Ivermectin 36mg single dose orally once only: The study will have two intervention arms. In the intervention Arm 1: 12mg oral Ivermectin will be given to the close family contacts fulfilling the inclusion- exclusion criteria for this study; of the newly diagnosed Covid-19 patient within 24 hours of diagnosis. The drug will be given orally and once only (under supervision). In the intervention Arm 2: 36 mg oral Ivermectin will be given to the close family contacts fulfilling the inclusion- exclusion criteria for this study; of the newly diagnosed Covid-19 patient within 24 hours of diagnosis. The drug will be given orally and once only (under supervision).Control Intervention1: Two Multivitamin tablets: In the control group - each participant will be given 2 (two) multivitamin tablets (available in the supply at the study institute). These tablets will be given orally; under-supervision and only once.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Ivermectin 12mg or Ivermectin 36mg single dose orally once only: The study will have two intervention arms. In the intervention Arm 1: 12mg oral Ivermectin will be given to the close family contacts fulfilling the inclusion- exclusion criteria for this study; of the newly diagnosed Covid-19 patient within 24 hours of diagnosis. The drug will be given orally and once only (under supervision). In the intervention Arm 2: 36 mg oral Ivermectin will be given to the close family contacts fulfilling the inclusion- exclusion criteria for this study; of the newly diagnosed Covid-19 patient within 24 hours of diagnosis. The drug will be given orally and once only (under supervision).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: Two Multivitamin tablets: In the control group - each participant will be given 2 (two) multivitamin tablets (available in the supply at the study institute). These tablets will be given orally; under-supervision and only once.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]